Sancilio is a leading brand that connects entrepreneurs with pharmaceutical product development experts, guiding them from discovery to commercialization in a cost-effective manner. They have a family of companies working together, including Sancilio & Company (SCI), Omega Blu (OBL), and Clearway Global (CGL). OBL specializes in the development and distribution of high-quality nutraceutical products, especially omega 3.

Their Omega Blu brand offers essential fatty acids that are renowned for their effectiveness. They have expanded their product range to include Vitamin D3, Turmeric3, Mylk3, and Multivits3, all of which are top-notch nutritional products available without a prescription. SCI focuses on rare and orphan diseases, utilizing their pharmaceutical development expertise.

Their patented product for treating Sickle Cell Disease (Altemia Brand) is set to enter the US, European, and Middle Eastern markets in 2023. It has shown promising results in clinical trials. CGL provides innovative solutions for small to medium-sized pharmaceutical and biotechnology companies, streamlining the development process and ensuring cost-effectiveness.

They leverage their experience in creating high-quality omega 3 therapeutics to develop unique applications for those suffering from omega 3 deficiencies. With a deep understanding of the pharmaceutical industry, Clearway Global offers pharmaceutical development services to newer companies, guiding them towards US FDA approval. They provide expert guidance, investor value creation strategies, regulatory support, and help with connections to cost-effective contract services.

Their experienced team members are located worldwide, saving companies up to 75% in development costs. In addition to their services, Sancilio also offers a range of nutritious products through Omega Blu, including the highest quality omega 3 capsules, Vitamin D3 supplements, Mylk3 calcium supplement, Turmeric3 curcumin, and Multivit3 multivitamins. Overall, Sancilio is dedicated to creating global solutions for rare diseases and providing high-quality products and services to entrepreneurs in the pharmaceutical industry.

Visit their websites for more information and to explore their offerings